News
| Feb 10 | Lightning Round: Trina Solar, Zoltek, Affymax and More |
| Feb 10 | 'Mad Money Lightning Round': Intuitive Surgical Heading Higher |
| Feb 10 | [video] Lightning Round |
| Feb 10 | 2012 Economic Outlook - Report Highlights Affymax, Inc. and Cavium Inc Marketwire |
| Feb 10 | DIARY-U.S. MEETINGS/WEEK AHEAD |
| Feb 09 | $AFFY CEO will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14 @ 3:00 p.m EST. by abubnic |
| Feb 08 | Affymax to Present at 14th Annual BIO CEO & Investor Conference Business Wire |
| Feb 08 | $AFFY still a printing machine by ACE52WeekHigh |
| Feb 07 | Out of $AFFY 2% gain, added $AMRN target $12 by Itradestocks123 |
| Feb 06 | $AFFY looks like 3200 puts sold Feb 8 strikes today by MaddStocks |
| Feb 06 | $AFFY pullback = getting ready to soar by Itradestocks123 |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
Affymetrix is a company that manufactures DNA microarrays; it is based in Santa Clara, California, United States. The company was founded by Dr. Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChips" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derives significant benefit from its patent portfolio in this area.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Affymax is up N/A over the last year vs S&P 500 Total Return up N/A, NPS Pharmaceuticals down N/A, and PDL BioPharma up N/A.
- AFFY Total Returns
- ^SPXTR Total Returns
- NPSP Total Returns
- PDLI Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these AFFY related companies
Pro Strategies Featuring AFFY
Did Affymax make it into our Pro Portfolio Strategies?
AFFY Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other AFFY Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AFFY | 10.47 | -0.06 | -0.57% | 372.21M |
| NAVG | 49.06 | -0.81 | -1.62% | 732.96M |
| ISSC | 3.97 | -0.04 | -1.00% | 66.38M |
| HCSG | 20.39 | -0.62 | -2.95% | 1.36B |
| NEPT | 2.58 | -0.17 | -6.18% | 124.56M |
| PRFZ | 66.55 | -0.84 | -1.25% | |
| SYMM | 6.10 | -0.19 | -3.02% | 260.65M |
| EVBN | 13.50 | 0.20 | 1.50% | 55.48M |
| STLY | 3.75 | -0.06 | -1.57% | 53.81M |
| FUND | 7.25 | -0.07 | -0.96% |
